|
| 37139822 | Nationwide use and Outcome of Minimally Invasive Distal Pancreatectomy in IDEAL Stage IV following a Training Program and Randomized Trial. | Ann Surg | 2024 |
| 37889954 | Comment on the RAPIDO Trial Point-Counterpoint Debate. | Dis Colon Rectum | 2024 |
| 34225302 | Chemoradiation and Local Excision Versus Total Mesorectal Excision for T2N0 Rectal Cancer: Comparison of Short- and Long-Term Outcomes From 2 Prospective Studies. | Ann Surg | 2023 |
| 37713932 | Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not. | ESMO Open | 2023 |
| 37894346 | <sup>89</sup>Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study. | Cancers (Basel) | 2023 |
| 37609761 | Relevance of shrinkage versus fragmented response patterns in rectal cancer. | Histopathology | 2023 |
| 37493212 | Rectal Cancer and Organ-Preservation: Safety First, Then the King. | Dis Colon Rectum | 2023 |
| 35680414 | Intraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A Multicenter Feasibility Dose-Escalation Study. | J Nucl Med | 2023 |
| 37060036 | Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial. | Breast Cancer Res | 2023 |
| 37182582 | Prognostic Value of T-Cell Density in the Tumor Center and Outer Margins in Gastric Cancer. | Mod Pathol | 2023 |
| 37004168 | Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer. | JNCI Cancer Spectr | 2023 |
| 36972213 | Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD). | Br J Surg | 2023 |
| 36996624 | Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial. | Eur J Cancer | 2023 |
| 36581138 | Authors' reply-A sensitivity analysis of the RAPIDO clinical trial. | Ann Oncol | 2023 |
| 36515514 | The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database. | Dis Colon Rectum | 2023 |
| 36871393 | The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer-results from the RAPIDO trial. | ESMO Open | 2023 |
| 36661037 | Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial. | Ann Surg | 2023 |
| 36383926 | Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial. | J Clin Oncol | 2023 |
| 34714423 | Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial. | Gastric Cancer | 2022 |
| 35740628 | Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer. | Cancers (Basel) | 2022 |
| 35442755 | Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial. | J Clin Oncol | 2022 |
| 35372704 | Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery. | Phys Imaging Radiat Oncol | 2022 |
| 35666080 | Survival trends of patients with non-metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates. | Cancer Commun (Lond) | 2022 |
| 35758193 | Microsatellite instability in rectal cancer: what does it mean? A study of two randomized trials and a systematic review of the literature. | Histopathology | 2022 |
| 35527207 | The survival gap between young and older patients after surgical resection for colorectal cancer remains largely based on early mortality: A EURECCA comparison of four European countries. | J Geriatr Oncol | 2022 |
| 35526835 | Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer. | J Mol Diagn | 2022 |
| 35447283 | Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial. | Radiother Oncol | 2022 |
| 36210321 | The Impact of Postoperative Complications on Short- and Long-Term Health-Related Quality of Life After Total Mesorectal Excision for Rectal Cancer. | Clin Colorectal Cancer | 2022 |
| 35863110 | Microsatellite instability and sex differences in resectable gastric cancer - A pooled analysis of three European cohorts. | Eur J Cancer | 2022 |
| 35129727 | Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials. | Gastric Cancer | 2022 |
| 35276669 | Quality of Life Is Associated With Survival in Patients With Gastric Cancer: Results From the Randomized CRITICS Trial. | J Natl Compr Canc Netw | 2022 |
| 34490529 | Malignant Features in Pretreatment Metastatic Lateral Lymph Nodes in Locally Advanced Low Rectal Cancer Predict Distant Metastases. | Ann Surg Oncol | 2022 |
| 34748122 | Health-Related Quality of Life After Nipple-Sparing Mastectomy: Results From the INSPIRE Registry. | Ann Surg Oncol | 2022 |
| 32750943 | Quantitative Whole Slide Assessment of Tumor-Infiltrating CD8-Positive Lymphocytes in ER-Positive Breast Cancer in Relation to Clinical Outcome. | IEEE J Biomed Health Inform | 2021 |
| 33547330 | The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival. | Sci Rep | 2021 |
| 33518367 | One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison. | Eur J Surg Oncol | 2021 |
| 33712984 | Neoadjuvant Short-Course Radiotherapy for Upper Third Rectal Tumors: Systematic Review and Individual Patient Data Metaanalysis of Randomized Controlled Trials. | Ann Surg Oncol | 2021 |
| 33512566 | Molecular Lymph Node Staging with One-Step Nucleic Acid Amplification and its Prognostic Value for Patients with Colon Cancer: The First Follow-up Study. | World J Surg | 2021 |
| 33662297 | Interpreting the RAPIDO trial: factors to consider - Authors' reply. | Lancet Oncol | 2021 |
| 33799475 | CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy. | Diagnostics (Basel) | 2021 |
| 34572852 | Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial. | Cancers (Basel) | 2021 |
| 34065112 | Intra-Tumoral Genomic Heterogeneity in Rectal Cancer: Mutational Status Is Dependent on Preoperative Biopsy Depth and Location. | Cancers (Basel) | 2021 |
| 34238931 | Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study. | NPJ Breast Cancer | 2021 |
| 34120810 | Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study. | Eur J Surg Oncol | 2021 |
| 34340874 | Preoperative risk factors for major postoperative complications after complex gastrointestinal cancer surgery: A systematic review. | Eur J Surg Oncol | 2021 |
| 34262618 | Largely varying patterns and trends of primary cancer-directed resection for gastric carcinoma with synchronous distant metastasis in Europe and the US: a population-based study calling for further standardization of care. | Ther Adv Med Oncol | 2021 |
| 33316218 | Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study. | Lancet Oncol | 2021 |
| 33227408 | Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial. | Ann Oncol | 2021 |
| 33109739 | Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR<sup>+</sup> Early-stage Breast Cancer for 10 Years of Endocrine Therapy. | Clin Cancer Res | 2021 |
| 33301740 | Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. | Lancet Oncol | 2021 |